title: Differential effect of leflunomide on concordant xenogeneic islet graft rejection and recurrence of autoimmune diabetes.
authors.affiliation: Department of General Surgery, Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL 60612, USA.
authors.forename: Z
authors.initials: Z
authors.lastname: Guo
authors.forename: D
authors.initials: D
authors.lastname: Mital
authors.forename: J
authors.initials: J
authors.lastname: Shen
authors.forename: A S
authors.initials: AS
authors.lastname: Chong
authors.forename: Y
authors.initials: Y
authors.lastname: Tian
authors.forename: P
authors.initials: P
authors.lastname: Foster
authors.forename: H
authors.initials: H
authors.lastname: Sankary
authors.forename: L
authors.initials: L
authors.lastname: McChesney
authors.forename: S C
authors.initials: SC
authors.lastname: Jensik
authors.forename: J W
authors.initials: JW
authors.lastname: Williams
mesh_terms: D000818:Animals; D015551:Autoimmunity / Q000187:drug effects*; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology / Q000473:pathology / Q000517:prevention & control / Q000601:surgery*; D006084:Graft Rejection / Q000517:prevention & control*; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D016381:Islets of Langerhans Transplantation; D007555:Isoxazoles / Q000008:administration & dosage*; D000077339:Leflunomide; D051379:Mice; D016688:Mice, Inbred NOD; D051381:Rats; D017207:Rats, Sprague-Dawley; D012008:Recurrence; D014183:Transplantation, Heterologous
chemical_list: D007166:Immunosuppressive Agents; D007555:Isoxazoles; D000077339:Leflunomide